Pharmacy

The documented clinical treatment strategy or management protocol associated with a physiological reaction event, such as an adverse drug reaction or anaphylaxis. Outlines the prescribed course of action for addressing the reaction, including medications, interventions, and follow-up care steps in the patient record.

The insurance policy identifier linked to a documented physiological reaction event, used to associate the adverse reaction encounter with the patient's health coverage. Referenced in claims processing and billing workflows to validate coverage and facilitate reimbursement for reaction-related treatments and services.

The clinically preferred or standardized display name for a documented physiological reaction, used when multiple naming conventions or synonyms exist. Ensures consistent terminology in patient-facing communications, clinical documentation, and cross-system reporting of adverse drug reactions and allergic responses.

The charged or billed cost associated with treatment or services rendered for a documented physiological reaction event. Used in healthcare billing and revenue cycle systems to record the financial value of adverse reaction-related encounters prior to insurance adjudication and payment processing.

A flag or boolean indicator designating whether a documented physiological reaction is the primary or principal adverse event in a patient's record when multiple reactions are present. Used in clinical documentation and reporting to prioritize the most clinically significant adverse drug reaction or allergic response for treatment and coding purposes.

Indicates the urgency or clinical importance ranking assigned to an adverse drug reaction or allergy response event, guiding triage and clinical decision-making. Used in allergy and adverse event tracking to determine which reactions require immediate intervention versus routine follow-up documentation.

Records the patient's heart rate in beats per minute measured at the time an adverse reaction or allergic response was observed. Used in clinical documentation to capture vital sign changes associated with the reaction event, supporting severity assessment and treatment decisions.

Captures the measurable amount or volume associated with an adverse reaction event, such as the dose quantity of the triggering substance or the volume of a bodily response. Used in adverse event and allergy tracking systems to support causality analysis and clinical documentation.

Records the patient's self-reported racial classification in the context of an adverse reaction event documentation. Used in pharmacovigilance and adverse event reporting to support population-level analysis of reaction incidence patterns across demographic groups and inform equitable care research.

Defines the acceptable minimum and maximum threshold values associated with an observed adverse reaction measurement or vital sign. Used in clinical decision support systems to flag when reaction-related measurements fall outside expected clinical boundaries and trigger appropriate alerts or escalations.

Captures the speed or frequency at which an adverse reaction manifests or progresses in a patient, such as the rate of symptom onset or escalation over time. Used in pharmacovigilance and clinical documentation to characterize reaction severity and support treatment protocol selection.

Records a standardized scored assessment of an adverse reaction's severity, clinical significance, or patient-reported impact. Used in allergy and adverse event documentation systems to quantify reaction burden, support comparison across episodes, and drive clinical escalation or de-escalation workflows.

Captures the proportional relationship between a triggering substance dose and the resulting adverse reaction severity or physiological response magnitude. Used in pharmacovigilance and adverse drug reaction reporting to support dose-response analysis and causality assessment in clinical data systems.

Documents the clinical rationale or suspected cause attributed to an adverse reaction or allergic response event. Used in allergy and adverse event tracking systems to record clinician explanations, suspected triggering agents, or contextual factors that help establish causality and guide future treatment decisions.

Records the date on which an adverse reaction report or allergic event notification was received by the clinical team, safety system, or reporting authority. Used in pharmacovigilance workflows to track reporting timelines, ensure regulatory compliance, and measure latency between event occurrence and documentation.

Stores an external identifier or pointer linking an adverse reaction record to related clinical documentation, published literature, regulatory reports, or source systems. Used in adverse event and allergy management systems to maintain traceability and cross-reference reaction data across healthcare information platforms.

Records the date on which an adverse reaction or allergic response episode was determined to have resolved or significantly improved. Used in allergy and adverse event tracking to measure reaction duration, assess treatment effectiveness, and support longitudinal patient safety documentation in clinical data systems.

Records the patient's respiratory rate in breaths per minute measured at the time an adverse reaction or allergic response was observed. Used in clinical documentation to capture respiratory vital sign changes as indicators of reaction severity, supporting assessment of anaphylaxis or other serious systemic responses.

Captures the clinical outcome or laboratory finding associated with an adverse reaction event, such as test results confirming the reaction type or severity measurement. Used in allergy and adverse event systems to document observable findings that validate the reaction occurrence and inform future exposure risk management.

Documents the body systems reviewed during clinical assessment of an adverse reaction event, following the structured Review of Systems methodology. Used in clinical documentation to capture which organ systems were evaluated in response to the reaction, supporting comprehensive adverse event characterization and care coordination.